Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Adagene Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 15
- +1 vs. Q1 2025
- Shares held
- 6.07M
- −1.55M (−20.3%) vs. Q1 2025
- Total value
- $11.8M
- +$237.9K (+2.1%) vs. Q1 2025
- New holders
- 3
- 2 more added
- Sold out
- 2
- 3 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADAG on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 35 | $81.0M |
| Q1 2026 | 25 | $9.70M |
| Q4 2025 | 17 | $6.03M |
| Q3 2025 | 17 | $11.3M |
| Q2 2025 | 15 | $11.8M |
| Q1 2025 | 14 | $11.6M |
| Q4 2024 | 15 | $20.3M |
| Q3 2024 | 13 | $25.3M |
| Q2 2024 | 14 | $33.7M |
| Q1 2024 | 17 | $34.3M |
| Q4 2023 | 11 | $15.5M |
| Q3 2023 | 10 | $6.16M |
| Q2 2023 | 10 | $6.02M |
| Q1 2023 | 11 | $6.02M |
| Q4 2022 | 9 | $5.58M |
| Q3 2022 | 11 | $7.60M |
| Q2 2022 | 15 | $15.4M |
| Q1 2022 | 15 | $29.7M |
| Q4 2021 | 16 | $67.3M |
| Q3 2021 | 19 | $126.6M |
| Q2 2021 | 16 | $80.5M |
| Q1 2021 | 27 | $115.5M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Adagene Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| General Atlantic LLC | 3,825,952 | $7.46M | 0.21% | 00.0% | Unchanged |
| SC China Holding Ltd | 1,343,364 | $2.62M | 0.13% | 00.0% | Unchanged |
| FMR LLC | 379,159 | $750.7K | 0.00% | −802,476−67.9% | Reduced |
| Mill Creek Capital Advisors, LLC | 199,610 | $389.2K | 0.01% | 00.0% | Unchanged |
| Kamunting Street Capital Management, L.P. | 126,032 | $245.8K | 0.20% | +126,032 | New |
| Morgan Stanley | 77,238 | $150.6K | 0.00% | −21,836−22.0% | Reduced |
| Fifth Lane Capital, LP | 27,500 | $54.5K | 0.07% | 00.0% | Unchanged |
| Marex Group plc | 24,000 | $46.8K | 0.00% | +4,577+23.6% | Added |
| Gordian Capital Singapore Pte Ltd | 24,000 | $46.8K | 0.07% | +5,100+27.0% | Added |
| Royal Bank of Canada | 16,850 | $33.0K | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 11,307 | $22.0K | 0.00% | +11,307 | New |
| Geode Capital Management, LLC | 10,309 | $20.4K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 635 | $1.24K | 0.00% | +635 | New |
| BNP Paribas Arbitrage, SA | 400 | $792 | 0.00% | −1,300−76.5% | Reduced |
| SBI Securities Co., Ltd. | 76 | $148 | 0.00% | 00.0% | Unchanged |
| FIL Ltd | 0 | $0 | 0.00% | −749,448−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −122,516−100.0% | Sold out |